Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer

Cancer

Volumn 118, Issue 6, 2012, Pages 1726-1737

  Ilie, Marius ^a,b,c   Hofman, Véronique ^a,b,c   Ortholan, Cécile ^d   Bonnetaud, Christelle ^b   Coëlle, Céline ^b   Mouroux, Jérôme ^a,b,c   Hofman, Paul ^a,b,c  

^a PASTEUR HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d PRINCESS GRACE HOSPITAL CENTER   (Monaco)

Author keywords

intratumoral CD66b positive neutrophil to CD8 positive T cell ratio; neutrophils; nonsmall cell lung cancer; prognosis; tissue microarrays

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 8; CD8 ANTIGEN; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CD8+ T LYMPHOCYTE; CELL DENSITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL PARAMETERS; INTRATUMORAL CD66B POSITIVE NEUTROPHIL TO CD8 POSITIVE T LYMPHOCYTE RATIO; LUNG NON SMALL CELL CANCER; MALE; MOLECULAR PATHOLOGY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME;

ADULT; AGED; ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; FEMALE; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUTROPHILS;

EID: 84857992714     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26456     Document Type: Article

References (60)

1. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ,. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000 [serial online]. BMC Cancer. 2002; 2: 37.
2. Blanchon F, Grivaux M, Asselain B, et al. Four-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index. Lancet Oncol. 2006; 7: 829-836. (Pubitemid 44464064)
3. Potti A, Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med. 2006; 355: 570-580. (Pubitemid 44200650)
4. Mantovani A, Allavena P, Sica A, Balkwill F,. Cancer-related inflammation. Nature. 2008; 454: 436-444.
5. Hofman PM,. Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis. World J Gastroenterol. 2010; 16: 5790-5800.
6. Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limon P,. The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol. 2010; 10: 554-567.
7. Lee HJ, Lee EK, Lee KJ, Hong SW, Yoon Y, Kim JS,. Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int J Cancer. 2006; 118: 2490-2497.
8. Yang P, Bamlet WR, Sun Z, et al. Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. Chest. 2005; 128: 445-452. (Pubitemid 40994509)
9. Wu QD, Wang JH, Condron C, Bouchier-Hayes D, Redmond HP,. Human neutrophils facilitate tumor cell transendothelial migration. Am J Physiol Cell Physiol. 2001; 280: C814-C822.
10. Coussens LM, Werb Z,. Inflammatory cells and cancer: think different! J Exp Med. 2001; 193: F23-F26. (Pubitemid 32524459)
11. Ishikawa K, Takenaga K, Akimoto M, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008; 320: 661-664. (Pubitemid 351928347)
12. Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, Musiani P,. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood. 2001; 97: 339-345. (Pubitemid 32060315)
13. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-674.
14. Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH,. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010; 29: 1093-1102.
15. Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, von der Maase H,. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol. 2009; 27: 4709-4717.
16. An X, Ding PR, Wang FH, Jiang WQ, Li YH,. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma [serial online]. Tumour Biol. 2011; 32: 317-324.
17. Cho H, Hur HW, Kim SW, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother. 2009; 58: 15-23.
18. Ohno Y, Nakashima J, Ohori M, Hatano T, Tachibana M,. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol. 2010; 184: 873-878.
19. Goldstraw P,. The seventh edition of TNM in lung cancer: what now? J Thorac Oncol. 2009; 4: 671-673.
20. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. Lyon, France: IARC Press; 2004.
21. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011; 6: 244-285.
22. Hofman P, Butori C, Havet K, et al. Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status. Br J Cancer. 2008; 98: 956-964. (Pubitemid 351341605)
23. Ilie M, Mazure NM, Hofman V, et al. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br J Cancer. 2010; 102: 1627-1635.
24. Schemper M, Smith TL,. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996; 17: 343-346. (Pubitemid 26342716)
25. Coussens LM, Werb Z,. Inflammation and cancer. Nature. 2002; 420: 860-867. (Pubitemid 36019639)
26. Nozawa H, Chiu C, Hanahan D,. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A. 2006; 103: 12493-12498. (Pubitemid 44267286)
27. Whiteside TL,. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008; 27: 5904-5912.
28. Rodriguez PC, Ernstoff MS, Hernandez C, et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009; 69: 1553-1560.
29. Qian BZ, Pollard JW,. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010; 141: 39-51.
30. Houghton AM,. The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances. Cell Cycle. 2010; 9: 1732-1737.
31. Gungor N, Pennings JL, Knaapen AM, et al. Transcriptional profiling of the acute pulmonary inflammatory response induced by LPS: role of neutrophils [serial online]. Respir Res. 2010; 11: 24.
32. de Visser KE, Eichten A, Coussens LM,. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006; 6: 24-37. (Pubitemid 43053650)
33. Stockley RA,. Neutrophils and the pathogenesis of COPD. Chest. 2002; 121 (5 suppl): 151S-155S. (Pubitemid 34497333)
34. Gungor N, Knaapen AM, Munnia A, et al. Genotoxic effects of neutrophils and hypochlorous acid. Mutagenesis. 2010; 25: 149-154.
35. Soo CC, Haqqani AS, Hidiroglou N, Swanson JE, Parker RS, Birnboim HC,. Dose-dependent effects of dietary alpha- and gamma-tocopherols on genetic instability in mouse Mutatect tumors. J Natl Cancer Inst. 2004; 96: 796-800. (Pubitemid 38771825)
36. Wistuba II,. Genetics of preneoplasia: lessons from lung cancer. Curr Mol Med. 2007; 7: 3-14. (Pubitemid 46322275)
37. Gungor N, Haegens A, Knaapen AM, et al. Lung inflammation is associated with reduced pulmonary nucleotide excision repair in vivo. Mutagenesis. 2010; 25: 77-82.
38. Balkwill F,. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009; 9: 361-371.
39. Bellocq A, Antoine M, Flahault A, et al. Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol. 1998; 152: 83-92. (Pubitemid 28028049)
40. Ji H, Houghton AM, Mariani TJ, et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene. 2006; 25: 2105-2112.
41. Mascaux C, Iannino N, Martin B, et al. The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer. 2005; 92: 131-139. (Pubitemid 40188446)
42. Wislez M, Fleury-Feith J, Rabbe N, et al. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma. Am J Pathol. 2001; 159: 1423-1433. (Pubitemid 32947972)
43. Trellakis S, Bruderek K, Dumitru CA, et al. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease [serial online] [published online ahead of print December 28, 2010]. Int J Cancer. 2010.
44. Kim R, Emi M, Tanabe K,. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007; 121: 1-14. (Pubitemid 46537674)
45. Sznurkowski JJ, Zawrocki A, Emerich J, Biernat W,. Prognostic significance of CD4+ and CD8+ T cell infiltration within cancer cell nests in vulvar squamous cell carcinoma. Int J Gynecol Cancer. 2011; 21: 717-721.
46. Yang L, Pang Y, Moses HL,. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 2010; 31: 220-227.
47. Fridlender ZG, Sun J, Kim S, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell. 2009; 16: 183-194.
48. Mantovani A,. The yin-yang of tumor-associated neutrophils. Cancer Cell. 2009; 16: 173-174.
49. Roberts AB, Wakefield LM,. The 2 faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci U S A. 2003; 100: 8621-8623. (Pubitemid 36899145)
50. Bierie B, Moses HL,. TGF-beta and cancer. Cytokine Growth Factor Rev. 2006; 17: 29-40.
51. Ju MJ, Qiu SJ, Fan J, et al. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. Am J Clin Pathol. 2009; 131: 498-510.
52. Gabrilovich DI, Nagaraj S,. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009; 9: 162-174.
53. Tvinnereim AR, Hamilton SE, Harty JT,. Neutrophil involvement in cross-priming CD8+ T cell responses to bacterial antigens. J Immunol. 2004; 173: 1994-2002. (Pubitemid 38971636)
54. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E,. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009; 137: 425-428.
55. Li YW, Qiu SJ, Fan J, et al. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection [serial online]. J Hepatol. 2011; 54: 497-505.
56. Murdoch C, Muthana M, Coffelt SB, Lewis CE,. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer. 2008; 8: 618-631.
57. Elghetany MT,. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis. 2002; 28: 260-274. (Pubitemid 34743759)
58. Winterbourn CC,. Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology. 2002; 181-182: 223-227. (Pubitemid 36015703)
59. Krawisz JE, Sharon P, Stenson WF,. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology. 1984; 87: 1344-1350. (Pubitemid 15201434)
60. Caruso RA, Bellocco R, Pagano M, Bertoli G, Rigoli L, Inferrera C,. Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol. 2002; 15: 831-837. (Pubitemid 34919775)